Results 21 to 30 of about 584,026 (314)

Hispanic/Latino‐Serving Hospitals Provide Less Targeted Temperature Management Following Out‐of‐Hospital Cardiac Arrest

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Variation exists in outcomes following out‐of‐hospital cardiac arrest (OHCA), but whether racial and ethnic disparities exist in post‐arrest provision of targeted temperature management (TTM) is unknown.
Nicholas A. Morris, Michael Mazzeffi, Patrick McArdle, Teresa L. May, Greer Waldrop, Sarah M. Perman, James F. Burke, Steven M. Bradley, Sachin Agarwal, Jose F. Figueroa, Neeraj Badjatia   +10 more
doaj   +1 more source

Cancer statistics for the US Hispanic/Latino population, 2021

Ca, 2021
The Hispanic/Latino population is the second largest racial/ethnic group in the continental United States and Hawaii, accounting for 18% (60.6 million) of the total population. An additional 3 million Hispanic Americans live in Puerto Rico. Every 3 years,
K. D. Miller, A. P. Ortiz, P. Pinheiro, Priti Bandi, Adair K. Minihan, Hannah E Fuchs, D. Martinez Tyson, G. Tortolero-Luna, S. Fedewa, A. Jemal, R. Siegel   +10 more
semanticscholar   +1 more source

A call to address structural barriers to Hispanic/Latino representation in clinical trials on Alzheimer's disease and related dementias: A micro‐meso‐macro perspective

Alzheimer's & Dementia, 2023
This perspective paper addresses the US Hispanic/Latino (herein, Latino) experience with regards to a significant public health concern—the underrepresentation of Latino persons in Alzheimer's disease and related dementias (AD/ADRD) clinical trials ...
M. Aranda, D. Marquez, D. Gallagher-Thompson, Adriana Perez, J. Rojas, C. Hill, Yarissa Reyes, P. Dilworth-Anderson, Elena Portacolonem   +8 more
semanticscholar   +1 more source

Understanding Hispanic/Latino Participation in Clinical Trials and Observational Studies, and Strategies to Increase Participation: A Targeted Literature Review

Journal of health care for the poor and underserved, 2023
:Hispanic/Latino representation in medical research remains poor. We describe factors affecting rates of recruitment, participation, adherence, and retention of Hispanics/Latinos in clinical studies in the United States and characterize proposed ...
B. Dreyfus, Lorena Kuri, M. Ferri, Patricia M. Doykos, M. Fazeli, Kimberly Hofer, Antonia Andonova, L. Ferri   +7 more
semanticscholar   +1 more source

It's More Than Language: Cultural Adaptation of a Proven Dementia Care Intervention for Hispanic/Latino Caregivers.

The gerontologist, 2022
Although Hispanic/Latino older adults are at disproportionate and increased risk for Alzheimer's disease and related dementias, few evidence-based supportive care interventions are specifically developed for or adapted for this population.
L. Parker, K. Marx, Manka Nkimbeng, Elma Johnson, Sokha Koeuth, J. Gaugler, L. Gitlin   +6 more
semanticscholar   +1 more source

Polygenic risk scores and kidney traits in the Hispanic/Latino population: The Hispanic Community Health Study/Study of Latinos

HGG Advances, 2023
Summary: Estimated glomerular filtration rate (eGFR) is used to evaluate kidney function and determine the presence of chronic kidney disease (CKD), a highly prevalent disease in the US1,2,3 that varies among subgroups of Hispanic/Latino individuals.4,5 ...
Laura Y. Zhou, Tamar Sofer, Andrea R.V.R. Horimoto, Gregory A. Talavera, James P. Lash, Jianwen Cai, Nora Franceschini   +6 more
doaj   +1 more source

Diabetes Incidence Among Hispanic/Latino Adults in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).

Diabetes Care, 2022
OBJECTIVE To examine diabetes incidence in a diverse cohort of U.S. Hispanic/Latinos. RESEARCH DESIGN AND METHODS The Hispanic Community Health Study/Study of Latinos is a prospective cohort study with participants aged 18-74 years from four U.S ...
Christina Cordero, N. Schneiderman, M. Llabre, Yanping Teng, M. Daviglus, C. Cowie, Jianwen Cai, G. Talavera, L. Gallo, R. Kaplan, Elizabeth M. Cespedes Feliciano, Rebeca Espinoza Giacinto, A. Giachello, Larissa M Avilés-Santa   +13 more
semanticscholar   +1 more source

Long-Term Effectiveness and Safety of Natalizumab in African American and Hispanic/Latino Patients with Early Relapsing–Remitting Multiple Sclerosis: STRIVE Data Analysis

Neurology and Therapy, 2023
Introduction In STRIVE, natalizumab treatment demonstrated effectiveness in clinical, magnetic resonance imaging (MRI), and patient-reported outcomes (PROs) in patients with early relapsing–remitting multiple sclerosis (RRMS).
Jai Perumal, Roumen Balabanov, Laura Balcer, Steven Galetta, Zhaonan Sun, Hanyue Li, Danette Rutledge, Robin L. Avila, Robert J. Fox   +8 more
doaj   +1 more source

Apolipoprotein E ε4 Allele-Based Differences in Brain Volumes Are Largely Uniform Across Late Middle Aged and Older Hispanic/Latino- and Non-Hispanic/Latino Whites Without Dementia

Frontiers in Aging Neuroscience, 2021
Hispanics/Latinos are at an equal or a greater risk for Alzheimer's disease (AD), yet risk factors remain more poorly characterized as compared to non-Hispanic/Latino Whites.
Ariana M. Stickel, Ariana M. Stickel, Andrew C. McKinnon, Andrew C. McKinnon, Stephanie Matijevic, Matthew D. Grilli, John Ruiz, Lee Ryan   +7 more
doaj   +1 more source

Heterogeneity of Lipoprotein(a) Levels Among Hispanic or Latino Individuals Residing in the US.

JAMA Cardiol, 2023
ImportanceLipoprotein(a) (Lp[a]) is a genetically determined risk-enhancing factor for atherosclerotic cardiovascular disease (ASCVD). The Lp(a) distribution among the diverse Hispanic or Latino community residing in the US has not been previously described, to the authors’ knowledge.ObjectiveTo determine the distribution of Lp(a) levels across a large
Joshi PH, Marcovina S, Orroth K, López JAG, Kent ST, Kaplan R, Swett K, Sotres-Alvarez D, Thyagarajan B, Slipczuk L, Sofer T, Daviglus ML, Talavera GA, Schneiderman N, Rodriguez CJ.   +14 more
europepmc   +3 more sources